Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2013 07:30 ET | Source: VIVUS, Inc.

VIVUS Reports First Quarter 2013 Financial Results

MOUNTAIN VIEW, Calif., May 8, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet...
May 07, 2013 07:00 ET | Source: VIVUS, Inc.

VIVUS Announces Richard Fante, Former President U.S. and CEO North America, AstraZeneca, to Serve as Senior Advisor

MOUNTAIN VIEW, Calif., May 7, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the Company) today announced that Richard Fante, former president U.S., CEO North America and regional vice president...
May 01, 2013 07:05 ET | Source: VIVUS, Inc.

VIVUS Announces Date of First Quarter 2013 Financial Results and Conference Call

MOUNTAIN VIEW, Calif., May 1, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will report financial results for the first quarter ended March 31, 2013 before the NASDAQ...
May 01, 2013 07:00 ET | Source: VIVUS, Inc.

New Guidelines From American Association of Clinical Endocrinologists Recommend Medical Treatment of Obesity

MOUNTAIN VIEW, Calif., May 1, 2013 (GLOBE NEWSWIRE) -- A new comprehensive treatment algorithm for diabetes from the American Association of Clinical Endocrinologists (AACE) is the first to recommend...
April 30, 2013 07:00 ET | Source: VIVUS, Inc.

VIVUS Appoints Robert N. Wilson to Board of Directors

MOUNTAIN VIEW, Calif., April 30, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced the appointment of Robert N. Wilson, chairman of Mevion Medical Systems and former vice chairman of...
April 26, 2013 09:25 ET | Source: VIVUS, Inc.

VIVUS Announces Positive Recommendation From CHMP Supporting Avanafil Approval in Europe

MOUNTAIN VIEW, Calif., April 26, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP)...
April 22, 2013 08:30 ET | Source: VIVUS, Inc.

VIVUS to Present at Four Upcoming Investor Conferences

MOUNTAIN VIEW, Calif., April 22, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that management will present an overview of the company at four investment conferences during the...
March 26, 2013 06:30 ET | Source: VIVUS, Inc.

VIVUS Announces $110 Million Synthetic Capped Royalty Financing

MOUNTAIN VIEW, Calif., March 26, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it has entered into a $110 million non-equity financing with an investment fund managed by...
March 08, 2013 15:15 ET | Source: VIVUS, Inc.

VIVUS Confirms Receipt of Notice of Nomination From First Manhattan Co.

MOUNTAIN VIEW, Calif., March 8, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet...
March 04, 2013 06:45 ET | Source: VIVUS, Inc.

VIVUS to Present at Three Investor Conferences in March 2013

MOUNTAIN VIEW, Calif., March 4, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that management will present an overview of the company at three investment conferences during the...